Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Chronic High Bowel Frequency in IPAA Patients
NCT07756359Phase 4Not yet recruiting
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 4 trial of tirzepatide in diarrhea, sponsored by University of North Carolina at Chapel Hill. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT07756359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07756359.